Related Experiment Video
Updated: Aug 8, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
T cell receptor induced intracellular redistribution of type I protein kinase A
Wenhong Zhou1, Leoncio Vergara, Rolf König
1Department of Microbiology and Immunology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA.
Insights
Cyclic AMP-dependent protein kinase A (PKA) type I regulates T-cell activation by relocating within the cell after T-cell receptor stimulation. This spatial redistribution of PKA type I is crucial for controlling T-cell responses.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- T-cell activation, proliferation, and cytokine secretion depend on regulated cyclic AMP levels.
- Cyclic AMP-dependent protein kinase A (PKA) is a key effector of cyclic AMP signaling in mammalian cells.
- Type I PKA isozyme plays an inhibitory role in T-cell activation.
Purpose of the Study:
- To investigate the role of spatial redistribution of PKA type I in regulating T-cell activation.
- To understand the temporal and spatial dynamics of PKA type I following T-cell receptor (TCR) stimulation.
Main Methods:
- Laser scanning confocal microscopy was used to visualize PKA type I localization in T cells.
- T-cell activation was induced via antigen engagement or antibody-mediated cross-linking of the TCR-associated CD3 complex.
- PKA type I and TCR distribution were monitored over time after stimulation.
Main Results:
- In resting T cells, PKA type I was uniformly distributed.
- Upon TCR stimulation, PKA type I rapidly redistributed to the opposite pole from the TCR concentration at the immunological synapse within 10 minutes.
- This segregation was maintained for at least 20 minutes, with partial overlap at 30 minutes, and returned to baseline distribution by 60 minutes.
Conclusions:
- TCR signaling induces a dynamic spatial redistribution of PKA type I, crucial for regulating T-cell activation.
- The observed PKA type I redistribution suggests a mechanism for targeting or excluding the enzyme from specific subcellular locations based on cyclic AMP levels.
- This dynamic localization of PKA type I is a key regulatory event in T-cell immune responses.
Abstract:
The productive activation of CD4(+) T lymphocytes, leading to proliferation and cytokine secretion, requires precise temporal regulation of intracellular cyclic AMP concentrations. The major effector molecule activated by cyclic AMP in mammalian cells is the cyclic AMP-dependent protein kinase A (PKA). The type I PKA isozyme mediates the inhibitory effects of cyclic AMP on T-cell activation. Using laser scanning confocal microscopy, we demonstrated that the regulation of PKA type I activity involves spatial redistribution of PKA type I molecules following T-cell receptor (TCR) stimulation. In resting T cells, PKA type I was located in membrane proximal regions and distributed equally across the cell. Shortly after antigen engagement, T cells and antigen-presenting cells formed an area of intense contact, known as the immunological synapse. TCR concentrated at the synapse, whereas PKA type I molecules redistributed to the opposite cell pole within 10 min after T-cell stimulation. Type I PKA redistribution was solely dependent on TCR signalling, because we observed the same temporal and spatial distribution after antibody-mediated cross-linking of the TCR-associated CD3 complex. Segregation of TCR and PKA type I molecules was maintained for at least 20 min. Thirty minutes after stimulation, PKA type I partially colocalized with the TCR. After 60 min, PKA type I distribution again approached the resting state. Considering that initial TCR signals lead to increases in intracellular cyclic AMP, PKA type I molecules may be targeted towards localized cyclic AMP accumulations or transported away from these areas, depending on the requirements of the cellular response.
More Related Videos
Related Concept Videos
Intracellular Signaling Cascades
Amplifying Signals via Enzymatic Cascade
Receptor Tyrosine Kinases
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways

